EUVIMEDEUVIMED entdecken
Crossref

Pretransplant T-cell immune imbalance predicts slow engraftment after autologous hematopoietic stem cell transplantation in lymphoma

Xi Quan, Huai-Bin Zhang, Long-Rong Ran, Zhi-Ming Luo, Nan Zhang, Xiao Hu, Jian-Chuan Deng, Yao Liu, Shi-Feng Lou

World Journal of Stem Cells · 26.08.2026 · 18 (8)

DOI: 10.4252/wjsc.122836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Stem Cells, online erschienen am 26.08.2026. Verfasst von Xi Quan und 8 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Autologous hematopoietic stem cell transplantation (auto-HSCT) is a cornerstone therapeutic strategy for lymphoma. Slow engraftment after auto-HSCT increases the risks of infection and hemorrhage, prolongs hospital stay, and is therefore a critical determinant of transplant safety and clinical outcomes. To date, clinical evidence on risk factors for slow engraftment after auto-HSCT in patients with lymphoma remains insufficient, particularly regarding the pretransplant immune microenvironment and lymphocyte subsets. AIM To explore clinical and immune risk factors and construct a prediction model for slow engraftment after auto-HSCT in patients with lymphoma. METHODS We retrospectively enrolled 166 patients with lymphoma who underwent auto-HSCT at two Chongqing centers from July 2022 to June 2025. Patients were divided into slow engraftment (neutrophil engraftment > 10 days or platelet engraftment > 12 days, based on the median times) and early engraftment groups. Baseline clinical features, transplantation parameters, pretransplant lymphocyte subsets, and inflammatory cytokines were collected. Univariate and multivariate logistic regression analyses were used to identify independent risk factors, construct a combined predictive model, and assess its performance. RESULTS Multivariate analysis identified advanced age, reinfused CD34+ cell dose < 3.5 × 106/kg, a higher proportion of CD8+ T cells, a lower absolute CD4+ T-cell count, and prolonged peritransplant fever as independent risk factors for slow engraftment after auto-HSCT in lymphoma patients. Patients receiving a high CD34+ cell dose (≥ 3.5 × 106/kg) achieved faster neutrophil and platelet engraftment than those in the low-dose group. Compared with patients with early engraftment, those with slow engraftment showed pretransplant T-cell subset imbalance and elevated interleukin-2 and interferon-γ levels. A prediction model integrating these variables demonstrated good predictive performance and outperformed individual indicators, achieving an area under the curve (AUC) of 0.780 for identifying patients at risk of slow engraftment after auto-HSCT. CONCLUSION Slow engraftment after auto-HSCT is associated with clinical and immune factors. Pretransplant T-cell imbalance predicts delayed engraftment, and a combined model improves risk prediction (AUC = 0.780).

Zitieren

APA

Quan, X., Zhang, H., Ran, L., Luo, Z., Zhang, N., Hu, X., Deng, J., Liu, Y., & Lou, S. (2026). Pretransplant T-cell immune imbalance predicts slow engraftment after autologous hematopoietic stem cell transplantation in lymphoma. World Journal of Stem Cells, 18(8). https://doi.org/10.4252/wjsc.122836

Vancouver

Quan X, Zhang H, Ran L, Luo Z, Zhang N, Hu X, et al. Pretransplant T-cell immune imbalance predicts slow engraftment after autologous hematopoietic stem cell transplantation in lymphoma. World Journal of Stem Cells. 2026;18(8). doi:10.4252/wjsc.122836

BibTeX
@article{Quan2026,
  author = {Quan, Xi and Zhang, Huai-Bin and Ran, Long-Rong and Luo, Zhi-Ming and Zhang, Nan and Hu, Xiao and Deng, Jian-Chuan and Liu, Yao and Lou, Shi-Feng},
  title = {Pretransplant T-cell immune imbalance predicts slow engraftment after autologous hematopoietic stem cell transplantation in lymphoma},
  journal = {World Journal of Stem Cells},
  year = {2026},
  volume = {18},
  number = {8},
  doi = {10.4252/wjsc.122836}
}
Kostenlos starten →